Endothelial Progenitor Cells
"Endothelial Progenitor Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells derived from BONE MARROW that circulate in the adult bloodstream and possess the potential to proliferate and differentiate into mature ENDOTHELIAL CELLS.
| Descriptor ID |
D066026
|
| MeSH Number(s) |
A11.148.174 A11.436.275.182
|
| Concept/Terms |
Endothelial Progenitor Cells- Endothelial Progenitor Cells
- Endothelial Progenitor Cell
- Progenitor Cell, Endothelial
- Progenitor Cells, Endothelial
- Circulating Endothelial Progenitor Cells
|
Below are MeSH descriptors whose meaning is more general than "Endothelial Progenitor Cells".
Below are MeSH descriptors whose meaning is more specific than "Endothelial Progenitor Cells".
This graph shows the total number of publications written about "Endothelial Progenitor Cells" by people in this website by year, and whether "Endothelial Progenitor Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endothelial Progenitor Cells" by people in Profiles.
-
Taylor GS, Shaw A, Scragg JH, Smith K, Campbell MD, McDonald TJ, Shaw JA, Ross MD, West DJ. Type 1 Diabetes Patients With Different Residual Beta-Cell Function but Similar Age, HBA1c, and Cardiorespiratory Fitness Have Differing Exercise-Induced Angiogenic Cell Mobilisation. Front Endocrinol (Lausanne). 2022; 13:797438.
-
Taylor GS, Shaw A, Smith K, Capper TE, Scragg JH, Cronin M, Bashir A, Flatt A, Campbell MD, Stevenson EJ, Shaw JA, Ross M, West DJ. Type 1 diabetes patients increase CXCR4+ and CXCR7+ haematopoietic and endothelial progenitor cells with exercise, but the response is attenuated. Sci Rep. 2021 07 15; 11(1):14502.
-
Chandrasekhar J, de Winter VC, Kalkman DN, Sartori S, Chandiramani R, Aquino MB, de Wilde P, Zeebregts D, Woudstra P, Beijk MA, Hájek P, Atzev B, Hudec M, Ong TK, Mates M, Borisov B, Warda HM, den Heijer P, Wojcik J, Iniguez A, Coufal Z, Lee M, Tijssen JG, Koch KT, Baber U, Dangas GD, Colombo A, de Winter RJ, Mehran R. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration. Cardiovasc Drugs Ther. 2021 04; 35(2):309-320.
-
de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. JACC Cardiovasc Interv. 2018 10 08; 11(19):1969-1978.
-
Shao Y, Li X, Wood JW, Ma JX. Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy. J Diabetes Complications. 2018 Oct; 32(10):966-973.
-
West DJ, Campbell MD, Gonzalez JT, Walker M, Stevenson EJ, Ahmed FW, Wijaya S, Shaw JA, Weaver JU. The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. Cardiovasc Diabetol. 2015 Jun 05; 14:71.